Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide in Peripheral Neuropathic Pain
NCT03777956Phase 2Terminated
- Sponsor
- Danish Pain Research Center
- Start
- Jan 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Peripheral neuropathic pain comparing Lacosamide with Placebo (2 arms). Primary endpoint: Change in pain intensity at 12 weeks. Started Jan 2019; status: terminated.
02
Drugs
lacosamide
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT03777956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03777956.